BSX
Boston Scientific Corp
43.90$
-1.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +37.1% | -82.9% | +395.7% | +23.2% | +45.3% | -62.8% | +137.7% | +4.4% | +1.6% | -74.5% | +323.6% | – | |
| – | +4.3% | -2.9% | +2.3% | +104.5% | -45.3% | -6.6% | +3.4% | +1.8% | +6.7% | -3.8% | +1.1% | – | |
| – | +0.0% | +6.8% | +209.5% | -131.3% | – | +7.2% | +1.4% | +5.3% | -10.1% | +16.9% | +4.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +95.2% | -309.3% | – | -81.1% | +252.3% | -690.3% | – | – | |
| – | +29.6% | -8.2% | -36.7% | +96.1% | -3.6% | -36.2% | +1.6% | -4.7% | +93.9% | -49.6% | +10.2% | – | |
| – | +434.5% | -72.9% | -4.9% | +426.6% | +159.6% | -86.5% | +125.2% | -55.4% | +2.0% | +15.4% | +231.0% | – | |
| – | -39.3% | -100.0% | – | – | -100.0% | – | – | – | – | – | – | – | |
| – | -27.9% | -32.8% | – | – | – | -50.0% | +27.8% | +78.2% | +7.6% | – | – | – | |
| – | – | – | – | – | – | +30.7% | -227.1% | -31.5% | -2.8% | +23.9% | – | – | |
| – | -6.3% | +10,360.0% | -98.5% | -70.8% | +2,957.1% | +8.9% | -245.9% | -69.4% | +76.9% | +41.3% | +57.7% | – | |
| – | -115.0% | – | -60.7% | -173.0% | – | – | -156.9% | – | -7.9% | -177.5% | – | – | |
| – | +40.2% | -111.7% | – | +6.1% | +66.6% | -69.6% | +209.6% | +6.0% | -12.8% | -83.1% | +648.0% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.